These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16645367)

  • 1. Myocardial preconditioning and cardioprotection by volatile anaesthetics.
    Siracusano L; Girasole V; Alvaro S; Chiavarino ND
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):86-95. PubMed ID: 16645367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myocardial protection by volatile anesthetics].
    Preckel B; Müllenheim J; Schlack W
    Anaesthesiol Reanim; 2002; 27(5):116-23. PubMed ID: 12451935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications].
    Chiari P; Bouvet F; Piriou V
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):383-96. PubMed ID: 15826789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic preconditioning: from molecular characterisation to clinical application--part I.
    Riksen NP; Smits P; Rongen GA
    Neth J Med; 2004 Nov; 62(10):353-63. PubMed ID: 15683090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?
    Minguet G; Joris J; Lamy M
    Eur J Anaesthesiol; 2007 Sep; 24(9):733-45. PubMed ID: 17555610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury.
    Ruiz-Meana M; Rodríguez-Sinovas A; Cabestrero A; Boengler K; Heusch G; Garcia-Dorado D
    Cardiovasc Res; 2008 Jan; 77(2):325-33. PubMed ID: 18006437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1.
    Weber NC; Toma O; Damla H; Wolter JI; Schlack W; Preckel B
    Eur J Pharmacol; 2006 Jun; 539(1-2):1-9. PubMed ID: 16716295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms.
    Zaugg M; Lucchinetti E; Uecker M; Pasch T; Schaub MC
    Br J Anaesth; 2003 Oct; 91(4):551-65. PubMed ID: 14504159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthetic preconditioning confers acute cardioprotection via up-regulation of manganese superoxide dismutase and preservation of mitochondrial respiratory enzyme activity.
    Chen CH; Liu K; Chan JY
    Shock; 2008 Feb; 29(2):300-8. PubMed ID: 17693941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adaptation of myocardium to ischemia. The early phase of ischemic preconditioning].
    Maslov LN; Lishmanov IuB; Solenkova NV
    Usp Fiziol Nauk; 2006; 37(3):25-41. PubMed ID: 17022466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischaemic preconditioning of the brain, mechanisms and applications.
    Steiger HJ; Hänggi D
    Acta Neurochir (Wien); 2007 Jan; 149(1):1-10. PubMed ID: 17151832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping preconditioning's signaling pathways: an engineering approach.
    Downey JM; Krieg T; Cohen MV
    Ann N Y Acad Sci; 2008 Mar; 1123():187-96. PubMed ID: 18375591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial preconditioning: mechanisms and man.
    Edwards RJ; Marber MS
    Int J Clin Pract; 1998 Sep; 52(6):395-401. PubMed ID: 9894376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic preconditioning: from molecular characterisation to clinical application--part II.
    Riksen NP; Smits P; Rongen GA
    Neth J Med; 2004 Dec; 62(11):409-23. PubMed ID: 15685892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.